Compare iShares Core High Dividend ETF (HDV) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core High Dividend ETF vs Intuitive Surgical, Inc. — how do they compare? iShares Core High Dividend ETF trades at $28.24, while Intuitive Surgical, Inc. trades at $351.3 (market cap $125.08B). The key difference: iShares Core High Dividend ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.
| HDV | ISRG | |
|---|---|---|
52-Week High | $28.36 | $592.85 |
52-Week Low | $23.64 | $345.42 |
Market Cap | — | $125.08B |
Sector | — | Health |
Enterprise Value | — | $116.45B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HDV trades at $28.18, down 0.25% on the day, with technical indicators showing a bullish trend supported by moving averages. Recent corporate actions include a 1:5 stock split in April 2026 and scheduled dividends for mid-2026. The ETF focuses on high-quality, high-yield U.S. large-cap value stocks, emphasizing defensive sectors like healthcare and energy.
Outlook remains positive due to strong technical momentum and quality screening, but risks include sector concentration in energy, which may introduce volatility. The ETF's low beta and focus on dividend sustainability appeal to income-focused investors, though competition from lower-cost alternatives like SCHD warrants monitoring.
Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.
The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
